Department of Laboratory Medicine, Dong-A University Medical Center, Dong-A University College of Medicine, Busan, Korea.
Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
Ann Lab Med. 2022 May 1;42(3):314-320. doi: 10.3343/alm.2022.42.3.314.
Genetic testing has become increasingly integrated into all areas of healthcare, and complex genetic testing usage continues to grow; thus, the demand for genetic counseling (GC) is likely to increase. However, it is unclear whether the current clinical GC capacity is sufficient for meeting the existing demand. This review describes the current issues, challenges, and future perspectives of GC in Korea based on a professional survey conducted among laboratory physicians. In view of the growing GC demand in the clinical setting, participants expressed a concern about the lack of support from the national healthcare insurance policy and legal requirements, such as certification, for GC practice. The implementation of genetic testing in the overall healthcare system in Korea is in an early phase. Proper implementation can be achieved through education and training of specialists, collaboration among healthcare personnel, proper regulatory oversight, genomic policies, and public awareness. Understanding the current GC capacity, issues, and challenges is a prerequisite for effective strategic planning by healthcare systems considering the expected growth in the demand for clinical genetic services over the next few decades.
基因检测已经越来越深入到医疗保健的各个领域,复杂的基因检测使用也在不断增加;因此,对遗传咨询(GC)的需求可能会增加。然而,目前临床 GC 能力是否足以满足现有需求尚不清楚。本综述基于对实验室医生进行的专业调查,描述了韩国目前 GC 存在的问题、挑战和未来展望。鉴于临床环境中 GC 需求的不断增长,参与者对国家医疗保健保险政策和 GC 实践的法律要求(如认证)缺乏支持表示关注。韩国将基因检测纳入整体医疗保健系统的阶段还处于早期。通过对专家进行教育和培训、医疗保健人员之间的协作、适当的监管监督、基因组政策和公众意识,可以实现这一目标。了解当前的 GC 能力、问题和挑战是医疗保健系统在未来几十年内考虑到对临床遗传服务需求预期增长的情况下进行有效战略规划的前提。